Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papilledema | 4 | 2016 | 78 | 0.670 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2018 | 8 | 0.620 |
Why?
|
| Cellulitis | 1 | 2018 | 62 | 0.600 |
Why?
|
| Scalp | 1 | 2018 | 57 | 0.590 |
Why?
|
| Pseudotumor Cerebri | 3 | 2016 | 58 | 0.580 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 85 | 0.560 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2011 | 49 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2018 | 3570 | 0.280 |
Why?
|
| Optic Nerve | 2 | 2016 | 114 | 0.220 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1894 | 0.210 |
Why?
|
| Vision Disorders | 2 | 2017 | 211 | 0.210 |
Why?
|
| Giant Cell Arteritis | 2 | 2019 | 58 | 0.170 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 49 | 0.160 |
Why?
|
| Diplopia | 1 | 2019 | 39 | 0.160 |
Why?
|
| Vision, Binocular | 1 | 2019 | 45 | 0.150 |
Why?
|
| Optic Chiasm | 1 | 2018 | 15 | 0.150 |
Why?
|
| Temporal Arteries | 1 | 2019 | 40 | 0.150 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2018 | 19 | 0.150 |
Why?
|
| Visual Acuity | 3 | 2019 | 816 | 0.150 |
Why?
|
| Retinal Artery | 1 | 2017 | 16 | 0.140 |
Why?
|
| Eye Foreign Bodies | 1 | 2017 | 15 | 0.140 |
Why?
|
| Metals | 1 | 2017 | 63 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 70 | 0.140 |
Why?
|
| Acetazolamide | 1 | 2016 | 30 | 0.130 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2016 | 24 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2018 | 197 | 0.130 |
Why?
|
| Lymphoma | 1 | 2018 | 322 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 220 | 0.120 |
Why?
|
| Horner Syndrome | 1 | 2015 | 12 | 0.120 |
Why?
|
| Neuromyelitis Optica | 2 | 2012 | 31 | 0.120 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 184 | 0.110 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 16 | 0.110 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2014 | 77 | 0.110 |
Why?
|
| Third Ventricle | 1 | 2014 | 27 | 0.110 |
Why?
|
| Pelvic Floor | 1 | 2013 | 34 | 0.110 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2013 | 27 | 0.110 |
Why?
|
| Career Choice | 1 | 2014 | 148 | 0.100 |
Why?
|
| Choroid | 1 | 2013 | 39 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2100 | 0.100 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2013 | 45 | 0.100 |
Why?
|
| Neurology | 1 | 2014 | 107 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 93 | 0.100 |
Why?
|
| Retinitis | 1 | 2012 | 18 | 0.100 |
Why?
|
| Cat-Scratch Disease | 1 | 2012 | 33 | 0.100 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2012 | 14 | 0.100 |
Why?
|
| Behavioral Symptoms | 1 | 2012 | 25 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2014 | 198 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 584 | 0.090 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2010 | 19 | 0.090 |
Why?
|
| Optic Neuritis | 1 | 2011 | 30 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 51 | 0.090 |
Why?
|
| Education, Medical | 1 | 2014 | 288 | 0.090 |
Why?
|
| Adult | 8 | 2018 | 29632 | 0.090 |
Why?
|
| Biopsy | 3 | 2019 | 1236 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 2010 | 88 | 0.080 |
Why?
|
| Glioma | 1 | 2014 | 489 | 0.080 |
Why?
|
| Humans | 18 | 2019 | 125086 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2010 | 436 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 3 | 2017 | 522 | 0.070 |
Why?
|
| Male | 9 | 2019 | 61463 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2013 | 854 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 26926 | 0.060 |
Why?
|
| Female | 11 | 2019 | 66747 | 0.060 |
Why?
|
| Fluorescein Angiography | 2 | 2017 | 138 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1662 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 19861 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5175 | 0.030 |
Why?
|
| Visual Field Tests | 1 | 2016 | 48 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 429 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2016 | 51 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 103 | 0.030 |
Why?
|
| Visual Fields | 1 | 2016 | 133 | 0.030 |
Why?
|
| Clonidine | 1 | 2015 | 36 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2015 | 34 | 0.030 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 26 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 184 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 208 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 684 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 16326 | 0.030 |
Why?
|
| New York | 1 | 2013 | 68 | 0.030 |
Why?
|
| Methotrexate | 1 | 2016 | 337 | 0.030 |
Why?
|
| Cocaine | 1 | 2015 | 207 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 305 | 0.030 |
Why?
|
| Craniotomy | 1 | 2014 | 109 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6597 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2016 | 371 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 299 | 0.030 |
Why?
|
| Bartonella henselae | 1 | 2012 | 20 | 0.030 |
Why?
|
| Prednisone | 1 | 2013 | 276 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 509 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1169 | 0.020 |
Why?
|
| Azithromycin | 1 | 2012 | 43 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2015 | 339 | 0.020 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2012 | 102 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 382 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4638 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 777 | 0.020 |
Why?
|
| Child | 3 | 2015 | 24384 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 12476 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 329 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2015 | 14005 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2452 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 880 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 2906 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 19351 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2426 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9052 | 0.010 |
Why?
|